NEOSTIGMINE METHYLSULFATE
These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION, USP, safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION, USP.NEOSTIGMINE METHYLSULFATE injection, for intravenous useInitial U.S. Approval: 1939
e47a4a4c-0e7c-40b6-9950-5b3adadcac22
HUMAN PRESCRIPTION DRUG LABEL
Jun 1, 2023
Amphastar Pharmaceuticals, Inc.
DUNS: 024736733
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
neostigmine methylsulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
neostigmine methylsulfate
Product Details
FDA regulatory identification and product classification information